Q
Quince Therapeutics D
D
QNCX
4.23000
USD
-0.17
(-3.86%)
مغلق
حجم التداول
15,513
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
235,532,703
العنوان: Quince Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.